Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis System
17 nov. 2021 10h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced a significant milestone: the company has shipped...
Cytek Biosciences Reports Third Quarter 2021 Financial Results
08 nov. 2021 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the third quarter ended September 30,...
Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business
03 nov. 2021 08h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has acquired the cell analysis business...
Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021
26 oct. 2021 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter...
Cytek® Biosciences Introduces New 25-Color Immunoprofiling Assay
07 oct. 2021 10h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- The field of medical research has a new tool to develop vaccines, personal immunotherapies, and cures for cancer and other infectious diseases using...
Cytek Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
02 sept. 2021 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today announced the company will be participating in the Morgan Stanley...
Cytek Biosciences Reports Second Quarter 2021 Financial Results
02 sept. 2021 16h03 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30,...
Cytek Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
02 août 2021 16h01 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that the...
Cytek Biosciences Announces Closing of Its Initial Public Offering
27 juil. 2021 18h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the closing of...
Cytek Biosciences Announces Pricing of Its Initial Public Offering
22 juil. 2021 22h43 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of...